Abstract:Background: Head and Neck Squamous Cell Carcinoma (HNSCC) is the 6th most common cancer worldwide. Little is known about changes in copy number (CN) in many cancer associated genes in this tumor type, which may contribute to carcinogenesis and could become useful treatment targets in the future. Many analyses of CN are complicated by the need to use formalin-fixed paraffin-embedded (FFPE) tissues posing technical challenges. We determined copy number alterations (CNA) using a novel, medium-throughput technology (NanoString nCounter) in order to determine common cancer associated CNAs and assess its performance in FFPE tissues. Results were compared with more established technologies such as SNP array, aCGH, and qPCR. Methods: We investigated CNA in 124 tumor specimens and 22 cell lines for 100 literature curated cancer genes using the NanoString nCounter. Most samples were OCT frozen tissues, with a small subset having both OCT frozen, and FFPE tissues. Slides were assessed for tumor content by a HNC pathologist and samples with at least 60% tumor content selected. DNA was extracted using standard column-based methods (Qiagen). We performed CN analysis in 124 frozen (+4 matching FFPE) HNSCC specimens and cell lines (Nanostring nCounter assay) focusing on a selection of cancer associated genes. Furthermore we used aCGH and SNP-CHIP to analyse 20 and 4 cell lines respectively two of which were covered by all three methods. FGFR1 was assessed by qPCR. For FFPE samples a special Nanostring probeset was used with 3-5 probes per gene to provide redundancy with degraded DNA samples. HPV status of samples was assessed by a nested PCR for E6. Results Copy number changes detected by Nanostring and aCGH correlated well. The Nanostring nCounter assay appeared more accurate in calling deletions, which were detected in MST1R, PBRM1, PTPRD for instance. We found amplifications in multiple samples and genes, e.g. CCND1, EGFR, MDM4, MYC, VEGFA, PAX9, ITGB4, SSND1, CTTN, FADD, FGF19, ORAOV1, PPFIA1, some of which were frequently (n>50 samples) or highly amplified (>30 copies). Some of these amplifications such as ORAOV1 and PPFIA1 seemed higher/more frequent in HPV(-) compared to HPV(+) samples. Samples with FGFR1 amplification were validated using qPCR and correlated very closely. FFPE sample processing was uncomplicated using the FFPE probeset. While some probes failed, using degraded FFPE derived DNA, the redundancy of probes allowed accurate calling of CNA that closely correlated with frozen sample results. Conclusions Copy number alterations are frequent in HNSCC and involve many cancer associated genes, including potentially targetable genes such as EGFR, MDM4, and PIK3CA. Most of the CN changes are recurrent. Amplifications and deletions to some extent differed depending on HPV status. The role and implications of these CN aberrations in a clinical setting need to be further elucidated and validated. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr LB-398. doi:1538-7445.AM2012-LB-398

Genome-wide Somatic Copy Number Alteration Analysis and Database Construction for Cervical Cancer.

Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk.

The Landscape of Somatic Copy Number Alterations in Head and Neck Squamous Cell Carcinoma

CaSNP: a Database for Interrogating Copy Number Alterations of Cancer Genome from SNP Array Data

Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors

Copy Number Aberrations from Affymetrix SNP 6.0 Genotyping Data-How Accurate Are Commonly Used Prediction Approaches?

The Study on Copy Number Alteration of Clear Cell Renal Cancer in Chinese Population

High-resolution Analysis of Copy Number Alterations and Associated Expression Changes in Ovarian Tumors.

Genome-wide Identification of Significant Aberrations in Cancer Genome

Functional Genomic Analysis of Chromosomal Aberrations in a Compendium of 8000 Cancer Genomes

A CNV Computational Model for Clonal Origin Analysis of Synchronous Multifocal Hepatobiliary and Pancreatic Tumors.

TAGCNA: A Method to Identify Significant Consensus Events of Copy Number Alterations in Cancer

Insights into the Clinical, Biological and Therapeutic Impact of Copy Number Alteration in Cancer

Abstract 2587: VCF2CNA: a Tool for Efficiently Detecting Copy Number Alteration Using VCF Genotype Data

The Repertoire of Copy Number Alteration Signatures in Human Cancer

Somatic Gene Copy Number Alterations in Colorectal Cancer: New Quest for Cancer Drivers and Biomarkers

Characterization of the Genomic Landscape in Cervical Cancer by Next Generation Sequencing

Progenetix: 12 years of oncogenomic data curation

Comparative Analysis of Methods for Identifying Recurrent Copy Number Alterations in Cancer.

Vcf2cna: A Tool For Efficiently Detecting Copy Number Alteration Using Vcf Genotype Data

Abstract LB-398: Detection of Copy Number Alterations in 124 Head and Neck Squamous Cell Carcinomas Using the Nanostring Ncounter Assay